
### [MONDO:0015126](http://purl.obolibrary.org/obo/MONDO_0015126)
**Label:** polyendocrinopathy

**Subclasses:** [MONDO:0016423](http://purl.obolibrary.org/obo/MONDO_0016423) (autoimmune polyendocrinopathy type 4), [MONDO:0016422](http://purl.obolibrary.org/obo/MONDO_0016422) (autoimmune polyendocrinopathy type 3), [MONDO:0010580](http://purl.obolibrary.org/obo/MONDO_0010580) (immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome), [MONDO:0015079](http://purl.obolibrary.org/obo/MONDO_0015079) (multiple polyglandular tumor), [MONDO:0017278](http://purl.obolibrary.org/obo/MONDO_0017278) (autoimmune polyendocrinopathy), [MONDO:0009411](http://purl.obolibrary.org/obo/MONDO_0009411) (autoimmune polyendocrine syndrome type 1), [MONDO:0008667](http://purl.obolibrary.org/obo/MONDO_0008667) (von Hippel-Lindau disease), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0007044](http://purl.obolibrary.org/obo/MONDO_0007044) (acrodysostosis 1 with or without hormone resistance), [MONDO:0013599](http://purl.obolibrary.org/obo/MONDO_0013599) (autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome), [MONDO:0017045](http://purl.obolibrary.org/obo/MONDO_0017045) (neuroectodermal-endocrine syndrome), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0010012](http://purl.obolibrary.org/obo/MONDO_0010012) (autoimmune polyendocrinopathy type 2), [MONDO:0012552](http://purl.obolibrary.org/obo/MONDO_0012552) (multiple endocrine neoplasia type 4), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0017169](http://purl.obolibrary.org/obo/MONDO_0017169) (multiple endocrine neoplasia), [MONDO:0008057](http://purl.obolibrary.org/obo/MONDO_0008057) (Carney complex, type 1), [MONDO:0017240](http://purl.obolibrary.org/obo/MONDO_0017240) (acrodysostosis with multiple hormone resistance), [MONDO:0008874](http://purl.obolibrary.org/obo/MONDO_0008874) (Bangstad syndrome), [MONDO:0009985](http://purl.obolibrary.org/obo/MONDO_0009985) (Retinohepatoendocrinologic syndrome), [MONDO:0007958](http://purl.obolibrary.org/obo/MONDO_0007958) (familial medullary thyroid carcinoma), [MONDO:0011424](http://purl.obolibrary.org/obo/MONDO_0011424) (Carney triad), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0011740](http://purl.obolibrary.org/obo/MONDO_0011740) (Carney-Stratakis syndrome), [MONDO:0013863](http://purl.obolibrary.org/obo/MONDO_0013863) (combined immunodeficiency due to LRBA deficiency), [MONDO:0011525](http://purl.obolibrary.org/obo/MONDO_0011525) (CNC2), [MONDO:0008082](http://purl.obolibrary.org/obo/MONDO_0008082) (multiple endocrine neoplasia type 2B), [MONDO:0013822](http://purl.obolibrary.org/obo/MONDO_0013822) (acrodysostosis 2 with or without hormone resistance), 

**Corr. equiv. classes:** [Orphanet:280651](http://www.orpha.net/ORDO/Orphanet_280651), [OMIM:606864](http://purl.obolibrary.org/obo/OMIM_606864), [OMIM:268040](http://purl.obolibrary.org/obo/OMIM_268040), [OMIM:155240](http://purl.obolibrary.org/obo/OMIM_155240), [Orphanet:282196](http://www.orpha.net/ORDO/Orphanet_282196), [OMIM:101800](http://purl.obolibrary.org/obo/OMIM_101800), [OMIM:614613](http://purl.obolibrary.org/obo/OMIM_614613), [OMIM:210740](http://purl.obolibrary.org/obo/OMIM_210740), [Orphanet:319340](http://www.orpha.net/ORDO/Orphanet_319340), [Orphanet:227982](http://www.orpha.net/ORDO/Orphanet_227982), [OMIM:610755](http://purl.obolibrary.org/obo/OMIM_610755), [Orphanet:100094](http://www.orpha.net/ORDO/Orphanet_100094), [OMIM:604287](http://purl.obolibrary.org/obo/OMIM_604287), [Orphanet:3453](http://www.orpha.net/ORDO/Orphanet_3453), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653), [Orphanet:276152](http://www.orpha.net/ORDO/Orphanet_276152), [OMIM:608837](http://purl.obolibrary.org/obo/OMIM_608837), [Orphanet:892](http://www.orpha.net/ORDO/Orphanet_892), [OMIM:160980](http://purl.obolibrary.org/obo/OMIM_160980), [OMIM:162300](http://purl.obolibrary.org/obo/OMIM_162300), [Orphanet:391487](http://www.orpha.net/ORDO/Orphanet_391487), [Orphanet:276161](http://www.orpha.net/ORDO/Orphanet_276161), [OMIM:269200](http://purl.obolibrary.org/obo/OMIM_269200), [Orphanet:652](http://www.orpha.net/ORDO/Orphanet_652), [Orphanet:97286](http://www.orpha.net/ORDO/Orphanet_97286), [Orphanet:227990](http://www.orpha.net/ORDO/Orphanet_227990), [Orphanet:99361](http://www.orpha.net/ORDO/Orphanet_99361), [OMIM:193300](http://purl.obolibrary.org/obo/OMIM_193300), [OMIM:240300](http://purl.obolibrary.org/obo/OMIM_240300), [OMIM:614162](http://purl.obolibrary.org/obo/OMIM_614162), [OMIM:131100](http://purl.obolibrary.org/obo/OMIM_131100), [Orphanet:37042](http://www.orpha.net/ORDO/Orphanet_37042), [Orphanet:139411](http://www.orpha.net/ORDO/Orphanet_139411), [OMIM:614700](http://purl.obolibrary.org/obo/OMIM_614700), [Orphanet:3087](http://www.orpha.net/ORDO/Orphanet_3087), [Orphanet:3143](http://www.orpha.net/ORDO/Orphanet_3143), [OMIM:304790](http://purl.obolibrary.org/obo/OMIM_304790), [Orphanet:247709](http://www.orpha.net/ORDO/Orphanet_247709), [Orphanet:445018](http://www.orpha.net/ORDO/Orphanet_445018), [OMIM:605244](http://purl.obolibrary.org/obo/OMIM_605244), [Orphanet:1227](http://www.orpha.net/ORDO/Orphanet_1227), [Orphanet:2676](http://www.orpha.net/ORDO/Orphanet_2676), 

**Class expressions from DL-Learner:**

- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) and (not ([HP:0001962](http://purl.obolibrary.org/obo/HP_0001962) (Palpitations))) 45.16%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 45.07%
- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) and (not ([HP:0000126](http://purl.obolibrary.org/obo/HP_0000126) (Hydronephrosis))) 43.62%
- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) 42.61%
- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 42.61%
- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 42.61%
- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 42.61%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) 42.11%
- [HP:0100007](http://purl.obolibrary.org/obo/HP_0100007) (Neoplasm of the peripheral nervous system) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 41.14%
- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 40.68%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) and [HP:0100007](http://purl.obolibrary.org/obo/HP_0100007) (Neoplasm of the peripheral nervous system) 40.36%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 40.10%
- Thing 40.08%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 40.08%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100007](http://purl.obolibrary.org/obo/HP_0100007) (Neoplasm of the peripheral nervous system) 36.73%


